AREV Life Sciences Global Corp. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CAD 0.254996 million compared to CAD 0.190577 million a year ago. Net loss was CAD 0.990311 million compared to CAD 1.05 million a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.07 a year ago. Diluted loss per share from continuing operations was CAD 0.05 compared to CAD 0.07 a year ago.